期刊文献+

原发性良性阵发性位置性眩晕的危险因素 被引量:11

Risk factors of primary benign paroxysmal positional vertigo
原文传递
导出
摘要 良性阵发性位置性眩晕(BPPV)是眩晕最常见的类型,分为原发性和继发性,头部外伤、手术和内耳疾病为公认的继发因素,但原发性BPPV的病因和发病机制尚不明。最近研究发现原发性BPPV与多种因素相关,本文就这些危险因素进行综述。 Benign paroxysmal positional vertigo (BPPV) is the most common kind of vertigo, which can be divided into idiopathic and secondary types. Head trauma, surgery, and inner ear diseases may induce the secondary BPPV, but the etiology and pathogenesis of idiopathic BPPV is still unknown. Recent studies indicate that multiple factors are associated with idiopathic BPPV; in this article we will review the risk factors of idiopathic BPPV.
作者 赵仁亮 刘涛 孙慧 贾庆霞 Zhao Renliang;Liu Tao;Sun Hui;Jia Qingxia(Department of Neurology,Qingdao University Affiliated Hospital,Qingdao 266003,China;Department Rehabilitation of Qingdao University Affiliated Hospital,Qingdao 266003,China)
出处 《中华全科医师杂志》 2016年第8期650-652,共3页 Chinese Journal of General Practitioners
关键词 良性阵发性位置性眩晕 危险因素 Benign paroxysmal positional vertigo Risk factors
  • 相关文献

参考文献3

二级参考文献30

  • 1Feig DI, Kang DH, Nakagawa T, Mazzali M, Johnson RJ. Uric acid and hypertension. Curr Hypertens Rep 2006; 8: 111-5.
  • 2Gertzberg N, Neumann P, Rizzo V, Johnson A. NAD(P)H oxidase mediates the endothelial barrier dysfunction induced by TNF-alpha. Am J Physiol Lung Cell Mol Physiol 2004; 286: L37-48.
  • 3Cave AC, Brewer AC, Narayanapanicker A, Ray R, Grieve DJ, Walker S, et al. NADPH oxidases in cardiovascular health and disease. Antioxid Redox Signal 2006; 8: 691-728.
  • 4Mazzali M, Hughes J, Kim YG, Jefferson JA, Kang DH, Gordon KL, et al. Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism. Hypertension 2001; 38: 1101-6.
  • 5Watanabe S, Kang DH, Feng L, Nakagawa T, Kanellis J, Lan H, et al. Uric acid, hominoid evolution, and the pathogenesis of salt-sensitivity. Hypertension 2002; 40: 355-60.
  • 6Itoh H, Higuchi H, Hiraoka N, Ito M, Konishi T, Nakano T, et al. Contraction of rat thoracic aorta strips by endothelin-1 in the absence of extracellular Ca2+. Br J Pharmacol 1991; 104: 847-52.
  • 7Cai L, Kang YJ. Oxidative stress and diabetic cardiomyopathy: a brief review. Cardiovasc Toxicol 2001; 1: 181-93.
  • 8Sautin YY, Nakagawa T, Zharikov S, Johnson RJ. Adverse effects of the classic antioxidant uric acid in adipocytes: NADPH oxidase-mediated oxidative/nitrosative stress. Am J Physiol Cell Physiol 2007; 293: C584-96.
  • 9Iglarz M, Schiffrin EL. Role of endothelin-1 in hypertension. Curr Hypertens Rep 2003; 5: 144-8.
  • 10Ergul A. Endothelin-1 and endothelin receptor antagonists as potential cardiovascular therapeutic agents. Pharmacotherapy 2002; 22: 54-65.

共引文献817

同被引文献75

引证文献11

二级引证文献128

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部